Artal International S.C.A.
SEC CIK 1218180 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| LXRX | LEXICON PHARMACEUTICALS, INC. | Dir, 10% | 408.4K | $46.50M | — | 3 | 2022-08-01 | 2026-02-17 |
Most active insiders at LXRX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Artal Group S.A. | Dir, 10% | $2.00M | — |
| 2 | DEBBANE RAYMOND | Dir | $723.0K | — |
| 3 | Martens Rachel Yap | SVP, Partnerships, Corp Strat | — | — |
| 4 | Gopinathan Suma | SVP, Discovery | — | — |
| 5 | Artal Participations S.a r.l. | Dir, 10% | — | — |
| 6 | Cheung Ivan | Dir | — | — |
| 7 | Exton Michael | CEO, Dir | — | — |
| 8 | Sullivan Diane E. | Dir | — | — |
| 9 | McDermott Wendy | SVP, Human Resources | — | — |
| 10 | Granowitz Craig B | SVP, Chief Medical Off | — | — |
| 17 | Artal International S.C.A. | Dir, 10% | — | — |
Transactions 3
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2026-02-19 | 2026-02-17 | LXRX | LEXICON PHARMACEUTICALS, INC. | Artal International S.C.A. | Dir, 10% | A - Grant | $65.00 | +41.3K | 408.4K | +11% | +$2.68M |
| I | 2022-08-09 | 2022-08-05 | LXRX | LEXICON PHARMACEUTICALS, INC. | Artal International S.C.A. | Dir, 10% | P - Purchase | $2.50 | +2.43M | 50.86M | +5% | +$6.07M |
| I | 2022-08-01 | 2022-08-01 | LXRX | LEXICON PHARMACEUTICALS, INC. | Artal International S.C.A. | Dir, 10% | P - Purchase | $2.50 | +16.17M | 48.43M | +50% | +$40.43M |
Purchase Sale Sale after option exercise All abbreviations